IMCD Buys US-based Mutchler

Foto: AVAVA/Shutterstock
Foto: AVAVA/Shutterstock

Just a day after announcing the purchase of Kenya’s Chemicals and Solvents,  Dutch specialty chemicals distributor IMCD said it has acquired US pharmaceutical industry supplier Mutchler. The US company Mutchler is a leading distributor of specialty pharmaceutical ingredients in both the continental US and Puerto Rico. Altogether, it has around 30 employees and posted 2015 revenue of $28 million.

IMCD said Mutchler is an excellent fit, given its asset-light business model and long-term relationships with leading global suppliers. “Following the acquisition of MF Cachat (now IMCD US) in June 2015, this is an important next step as it expands our US operations into the pharmaceutical market, a strategic sector for IMCD,” said Marcus Jordan, president of IMCD Holdings US.

Financial terms of the deal were not disclosed.

Virtual Event

Downstream Purification
Bioprocess Forum

Downstream Purification

Save the Date: November 21+25, 2025
Join leading scientists, process engineers, and biomanufacturing innovators for a two-day virtual event exploring the latest breakthroughs in downstream purification.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.